Viewing Study NCT06390956


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-03 @ 7:27 AM
Study NCT ID: NCT06390956
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2024-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
Sponsor: University of Utah
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module